7:05 PM
 | 
May 12, 2014
 |  BC Extra  |  Financial News

Lysosomal raises $4.8 million in seed financing

Lysosomal Therapeutics Inc. (Cambridge, Mass.) raised $4.8 million in a seed financing led by Atlas Venture. Hatteras Venture Partners; Lilly Ventures; Sanofi-Genzyme BioVentures; Roche Venture Fund; Partners Innovation Fund; Orion Equity Partners; and angel...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >